Anshul Thakral

Anshul Thakral is Chief Executive Officer of Fortrea (Nasdaq: FTRE), having joined the company in August 2025. He also serves as a member of Fortrea’s Board of Directors.

Anshul has more than 25 years of experience in the CRO, pharmaceutical and biotech industries as a general manager, management consultant, commercial leader and entrepreneur. He served as Co-Founder and Chief Executive Officer of Launch Therapeutics since its founding in March 2022. From July 2016 to February 2022, Anshul served in increasing levels of seniority at PPD, from Global Head of PPD Biotech to Chief Commercial Officer and Executive Vice President of Peri- and Post-Approval Services at PPD. Before PPD, Anshul ran the global life sciences business unit at Gerson Lehrman Group (GLG) from March 2014 to June 2016 and served as a consultant at McKinsey & Company from August 2006 to March 2014, where he was an associate principal in the healthcare practice, counselling senior management and CEOs of global pharmaceutical and biotechnology companies.

Anshul currently serves on the Board of Directors of Orsini Specialty Pharmacy, a leader in pharmacy solutions for rare disease and complex therapy programs.

Anshul earned his Bachelor of Science and Master of Science in Engineering in Biomedical Engineering from Johns Hopkins University and his Master of Business Administration from the Wharton School at the University of Pennsylvania.